Patch Angioplasty for the Treatment of Hemodialysis Access Dysfunction.

IF 0.7
Xiang Li, Qianling Ye, Li Zhang, Weikang Guan, Huanhuan Song, Cunliang Zeng, Chaoyang Li, Ming Xie, Bin Zhao, Huaping Wu
{"title":"Patch Angioplasty for the Treatment of Hemodialysis Access Dysfunction.","authors":"Xiang Li, Qianling Ye, Li Zhang, Weikang Guan, Huanhuan Song, Cunliang Zeng, Chaoyang Li, Ming Xie, Bin Zhao, Huaping Wu","doi":"10.1177/15385744251387751","DOIUrl":null,"url":null,"abstract":"<p><p>BackgroundThe treatment of hemodialysis access dysfunction include creating a new fistula, balloon dilation, or stent implantation. However, these options are not suitable for all patients. We adopted patch angioplasty to reconstruct the hemodialysis access and observed this group of cases to evaluate the feasibility, effectiveness, and safety of this surgical method.MethodsBetween 2021 and 2024, we performed 14 cases of patch angioplasty using PTFE patch material. We recorded the time of fistula establishment, time of patch angioplasty, surgical site, transitional dialysis status using central venous catheter, complications, and patency of the fistula in this group of cases.ResultsAll 14 patients successfully underwent patch angioplasty, with a technical success rate of 100%. During follow-up, 3 patients died respectively 2, 8, 9 months post-operation. The longest follow-up time was 38 months. The primary patency rates for target lesions were as follows: 92.3% at 3 months (12/13), 81.8% at 6 months (9/11), 77.8% at 12 months (7/9), and 57.1% at 24 months (4/7). The cumulative patency rates were: 3 months 100% (13/13), 6 months 90.9% (10/11), 12 months 88.9% (8/9), and 24 months 71.4% (5/7). No cases experienced infection, bleeding, pseudoaneurysm, or steal syndrome.ConclusionsPTFE patch angioplasty for hemodialysis access reconstruction yields a high technical success rate and serves as an effective solution after hemodialysis access dysfunction. It has high safety and good patency rates, making it a recommended method for access reconstruction.</p>","PeriodicalId":94265,"journal":{"name":"Vascular and endovascular surgery","volume":" ","pages":"15385744251387751"},"PeriodicalIF":0.7000,"publicationDate":"2025-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vascular and endovascular surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/15385744251387751","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

BackgroundThe treatment of hemodialysis access dysfunction include creating a new fistula, balloon dilation, or stent implantation. However, these options are not suitable for all patients. We adopted patch angioplasty to reconstruct the hemodialysis access and observed this group of cases to evaluate the feasibility, effectiveness, and safety of this surgical method.MethodsBetween 2021 and 2024, we performed 14 cases of patch angioplasty using PTFE patch material. We recorded the time of fistula establishment, time of patch angioplasty, surgical site, transitional dialysis status using central venous catheter, complications, and patency of the fistula in this group of cases.ResultsAll 14 patients successfully underwent patch angioplasty, with a technical success rate of 100%. During follow-up, 3 patients died respectively 2, 8, 9 months post-operation. The longest follow-up time was 38 months. The primary patency rates for target lesions were as follows: 92.3% at 3 months (12/13), 81.8% at 6 months (9/11), 77.8% at 12 months (7/9), and 57.1% at 24 months (4/7). The cumulative patency rates were: 3 months 100% (13/13), 6 months 90.9% (10/11), 12 months 88.9% (8/9), and 24 months 71.4% (5/7). No cases experienced infection, bleeding, pseudoaneurysm, or steal syndrome.ConclusionsPTFE patch angioplasty for hemodialysis access reconstruction yields a high technical success rate and serves as an effective solution after hemodialysis access dysfunction. It has high safety and good patency rates, making it a recommended method for access reconstruction.

贴片血管成形术治疗血液透析通路功能障碍。
血液透析通路功能障碍的治疗包括造瘘、球囊扩张或支架植入。然而,这些选择并不适合所有患者。我们采用贴片血管成形术重建血液透析通路,并观察本组病例,评价该手术方法的可行性、有效性和安全性。方法在2021年至2024年期间,我们使用PTFE补片材料进行了14例补片血管成形术。我们记录了这组病例的瘘管建立时间、补片血管成形术时间、手术部位、中心静脉导管过渡透析状态、并发症和瘘管通畅程度。结果14例患者均成功行膜片血管成形术,技术成功率100%。随访中,3例患者分别于术后2、8、9个月死亡。最长随访时间为38个月。靶病变的原发性通畅率为:3个月92.3%(12/13),6个月81.8%(9/11),12个月77.8%(7/9),24个月57.1%(4/7)。累计通畅率为:3个月100%(13/13),6个月90.9%(10/11),12个月88.9%(8/9),24个月71.4%(5/7)。没有病例出现感染、出血、假性动脉瘤或偷窃综合征。结论sptfe补片血管成形术用于血液透析通路重建技术成功率高,是解决血液透析通路功能障碍的有效方法。它具有高安全性和良好的通畅率,是一种推荐的通道重建方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信